Calculus Capital: Investments against COVID-19 UK Investors

Entity: Calculus Capital
Category: UK Investors
Description: At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile. They look to make £2-5 million investments in established companies with proven management teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

+ Investing in:

. Mologic

Technology: COVID UK Funding&Support
Headquarters: United Kingdom
Investment Stage: N/A
Number Of Exists: N/A
Founded Date: N/A
Industry: COVID UK Non-governmental Bodies
Employee Number: N/A
Investor Type: N/A
Funding Status: N/A